291 related articles for article (PubMed ID: 32198896)
1. Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy.
Zhu X; Chen M; Wang H; Guo Y; Chau MHK; Yan H; Cao Y; Kwok YKY; Chen J; Hui ASY; Zhang R; Meng Z; Zhu Y; Leung TY; Xiong L; Kong X; Choy KW
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):459-465. PubMed ID: 32198896
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of expanded non-invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly.
Maya I; Salzer Sheelo L; Brabbing-Goldstein D; Matar R; Kahana S; Agmon-Fishman I; Klein C; Gurevitch M; Basel-Salmon L; Sagi-Dain L
Ultrasound Obstet Gynecol; 2023 Jun; 61(6):698-704. PubMed ID: 36776119
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies.
Sagi-Dain L; Cohen Vig L; Kahana S; Yacobson S; Tenne T; Agmon-Fishman I; Klein C; Matar R; Basel-Salmon L; Maya I
Genet Med; 2019 Nov; 21(11):2462-2467. PubMed ID: 31123319
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal abnormalities detected by karyotyping and microarray analysis in twins with structural anomalies.
Li L; He Z; Huang X; Lin S; Wu J; Huang L; Wan Y; Fang Q
Ultrasound Obstet Gynecol; 2020 Apr; 55(4):502-509. PubMed ID: 30977228
[TBL] [Abstract][Full Text] [Related]
5. Residual risk of clinically significant copy number variations in fetuses with nasal bone absence or hypoplasia after excluding non-invasive prenatal screening-detectable findings.
Xia Z; Zhou R; Xu Y; Li Y; Tan J; Luo C; Meng L; Huang M; Qiao F; Hu P; Mao P; Wu Y; Xu Z; Wang Y
Clin Chim Acta; 2024 Jan; 553():117744. PubMed ID: 38158003
[TBL] [Abstract][Full Text] [Related]
6. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
Xu L; Huang H; Lin N; Wang Y; He D; Zhang M; Chen M; Chen L; Lin Y
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):242-247. PubMed ID: 31364782
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes.
Liang D; Cram DS; Tan H; Linpeng S; Liu Y; Sun H; Zhang Y; Tian F; Zhu H; Xu M; Wang H; Yu F; Wu L
Genet Med; 2019 Sep; 21(9):1998-2006. PubMed ID: 30828085
[TBL] [Abstract][Full Text] [Related]
9. Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies.
Stern S; Hacohen N; Meiner V; Yagel S; Zenvirt S; Shkedi-Rafid S; Macarov M; Valsky DV; Porat S; Yanai N; Frumkin A; Daum H
Ultrasound Obstet Gynecol; 2021 May; 57(5):813-820. PubMed ID: 32202684
[TBL] [Abstract][Full Text] [Related]
10. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
11. Analyzing false-negative results detected in low-risk non-invasive prenatal screening cases.
Lin Y; Liang D; Wang Y; Li H; Liu A; Hu P; Xu Z
Mol Genet Genomic Med; 2020 Apr; 8(4):e1185. PubMed ID: 32067421
[TBL] [Abstract][Full Text] [Related]
12. [The value of noninvasive prenatal screening for the detection of fetal chromosome 16 aneuploidy].
Wang T; Wu J; Yang J; Lu J; Guo L; Du L; Yin A
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):135-138. PubMed ID: 32034738
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal microarray analysis in fetuses with high-risk prenatal indications: A retrospective study in China.
Luo X; Zhu H; Wang L; Xiao B; Fan Y; Ye H; Ying X; Qiu W; Zhang H; Han L; Gu X; Yu Y; Wang L
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):299-304. PubMed ID: 33678331
[TBL] [Abstract][Full Text] [Related]
14. A two-year prospective study assessing the performance of fetal chromosomal microarray analysis and next-generation sequencing in high-risk pregnancies.
Ridnõi K; Muru K; Keernik M; Pajusalu S; Ustav EL; Tammur P; Mölter-Väär T; Kahre T; Šamarina U; Asser K; Szirko F; Reimand T; Õunap K
Mol Genet Genomic Med; 2021 Oct; 9(10):e1787. PubMed ID: 34486251
[TBL] [Abstract][Full Text] [Related]
15. Performance of noninvasive prenatal screening for fetal sex chromosome aneuploidies in a cohort of 116,862 pregnancies.
Xu Y; Lou J; Qian Y; Jin P; Qian Y; Hong J; Xu Y; Yin Y; Yi S; Dong M
Expert Rev Mol Diagn; 2024 May; 24(5):467-472. PubMed ID: 38526221
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities.
Fiorentino F; Napoletano S; Caiazzo F; Sessa M; Bono S; Spizzichino L; Gordon A; Nuccitelli A; Rizzo G; Baldi M
Eur J Hum Genet; 2013 Jul; 21(7):725-30. PubMed ID: 23211699
[TBL] [Abstract][Full Text] [Related]
17. Performance of Cell-Free DNA Screening for Fetal Common Aneuploidies and Sex Chromosomal Abnormalities: A Prospective Study from a Less Developed Autonomous Region in Mainland China.
Lai Y; Zhu X; He S; Dong Z; Tang Y; Xu F; Chen Y; Meng L; Tao Y; Yi S; Su J; Huang H; Luo J; Leung TY; Wei H
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33806256
[TBL] [Abstract][Full Text] [Related]
18. Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study.
Moshonov R; Hod K; Azaria B; Abadi-Korek I; Berger R; Shohat M
PLoS One; 2021; 16(4):e0250734. PubMed ID: 33901244
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program.
Vogel I; Petersen OB; Christensen R; Hyett J; Lou S; Vestergaard EM
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):480-486. PubMed ID: 28608362
[TBL] [Abstract][Full Text] [Related]
20. Identification of copy number variations associated with congenital heart disease by chromosomal microarray analysis and next-generation sequencing.
Zhu X; Li J; Ru T; Wang Y; Xu Y; Yang Y; Wu X; Cram DS; Hu Y
Prenat Diagn; 2016 Apr; 36(4):321-7. PubMed ID: 26833920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
